Riskpilot← Back to searchSign inGet full accessSEE AS
ASActiveOrg 915454879Sandviksveien 176, 1337 SandvikaMedical specialists activities · NACE 8622Est. 20151 employees
Revenue 2024
NOK 6,1M
+6% vs 2023
EBITDA margin
54.8%
+1% vs 2023
Equity ratio
95.9%
Financial strength
Net profit 2024
NOK 3,1M
+2% vs 2023
| Revenue | NOK 6,1M | +6% |
| EBITDA | NOK 3,4M | +1% |
| Net profit | NOK 3,1M | +2% |
| Total assets | NOK 25M | +14% |
| Equity | NOK 24M | +15% |
| Employees | 1 | — |
Legal name
SEE AS
Org number
915454879
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
29. mai 2015
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet, øyelege spesialist, foreta egne investeringer i alle aktiva klasser herunder kjøp- salg og utleie av eiendom, deltagelse i andre selskap samt hva som måtte stå i forbindelse med dette.
Address
Sandviksveien 176, 1337 Sandvika
Phone
+4767575780
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 521 | 5 017 | 5 563 | 6 121 | 5 839 | 5 415 | 5 517 | 5 615 | 5 789 | 6 121 |
| Staff expenses | −761 | −633 | −706 | −856 | −860 | −902 | −984 | −997 | −1 022 | −1 149 |
| EBITDA | 2 904 | 3 311 | 3 122 | 3 052 | 3 145 | 2 984 | 2 966 | 3 080 | 3 326 | 3 352 |
| Depreciation & amort. | −12 | −9 | −8 | −6 | −5 | −19 | −247 | −172 | −221 | −129 |
| EBIT | 2 892 | 3 302 | 3 114 | 3 046 | 3 140 | 2 965 | 2 719 | 2 908 | 3 105 | 3 223 |
| Net financials | 43 | 95 | 204 | 149 | 306 | 827 | 229 | 344 | 631 | 647 |
| Profit before tax | 2 935 | 3 397 | 3 318 | 3 195 | 3 446 | 3 791 | 2 948 | 3 252 | 3 737 | 3 870 |
| Tax | 795 | 828 | 750 | 712 | 708 | 671 | 609 | 654 | 713 | 797 |
| Net profit | 2 140 | 2 569 | 2 568 | 2 483 | 2 738 | 3 121 | 2 339 | 2 598 | 3 023 | 3 073 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 611 | 6 937 | 9 477 | 11 500 | 14 230 | 17 337 | 19 722 | 19 670 | 21 919 | 25 035 |
| Equity | 2 971 | 5 557 | 8 125 | 10 609 | 13 347 | 16 468 | 15 307 | 17 905 | 20 928 | 24 002 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 56 | 38 | 33 | 15 | 0 |
| Short-term debt | 1 640 | 1 380 | 1 352 | 891 | 883 | 813 | 4 377 | 1 732 | 975 | 1 033 |
| Total debt | 1 640 | 1 380 | 1 352 | 891 | 883 | 869 | 4 415 | 1 765 | 991 | 1 033 |
EBITDA margin
54.8%
This company
15.8%
Market median
+247% vs market
20152024
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
20152024
Return on equity
12.8%
This company
18.4%
Market median
+30% vs market
20152024
Net profit margin
50.2%
This company
8.1%
Market median
+520% vs market
20152024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20152024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TØ Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SEE AS 
BÆRUM ØYEKLINIKK ASBoard members of SEE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tor Øivind Grøndahl | Chief Executive Officer | 0 companies |
| Aase Høviskeland | Board of Directors | 0 companies |